Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Minh H. Dinh"'
Autor:
Benoit You, Vasudha Sehgal, Balakrishna Hosmane, Xin Huang, Peter J. Ansell, Minh H. Dinh, Katherine Bell-McGuinn, Xizhi Luo, Gini F. Fleming, Michael Friedlander, Michael A. Bookman, Kathleen N. Moore, Karina D. Steffensen, Robert L. Coleman, Elizabeth M. Swisher
Publikováno v:
Journal of Clinical Oncology. 41:107-116
PURPOSE In VELIA trial, veliparib combined with carboplatin-paclitaxel, followed by maintenance (veliparib-throughout) was associated with improved progression-free survival (PFS) compared with carboplatin-paclitaxel alone in patients with high-grade
Autor:
D. Ross Camidge, Martin Dunbar, Jyoti D. Patel, Jeffrey M. Clarke, Bruce A. Bach, Eddie Thara, Francisco Robert, Silpa Nuthalapati, Ebenezer A. Kio, Minh H. Dinh
Publikováno v:
Lung Cancer. 161:180-188
Objectives Both combinations of the PARP inhibitor veliparib plus platinum doublet chemotherapy (CT), and the programmed death receptor-1 (PD-1) inhibitor nivolumab plus CT have demonstrated encouraging efficacy for treatment of non-small cell lung c
Autor:
Aikou Okamoto, Ana Oaknin, Elizabeth M. Swisher, Shibani Nicum, Mika Mizuno, Robert L. Coleman, Karina Dahl Steffensen, Sudipta Bhattacharya, Gini F. Fleming, Paul DiSilvestro, Mark A. Morgan, Charles A. Leath, Peter Ansell, Christine K. Ratajczak, Andrea R. Hagemann, Carol Aghajanian, Kathleen N. Moore, Michael Friedlander, Joo-Hyun Nam, Danielle Sullivan, Noa Ben-Baruch, Katherine M. Bell-McGuinn, Minh H. Dinh, Bruce A. Bach, Michael A. Bookman, Theresa L. Werner, Mark F. Brady, Jesús García-Donas, N.G. Cloven, Sally Baron-Hay, Ramey D. Littell, David Cella
Publikováno v:
Coleman, R L, Fleming, G F, Brady, M F, Swisher, E M, Steffensen, K D, Friedlander, M, Okamoto, A, Moore, K N, Efrat Ben-Baruch, N, Werner, T L, Cloven, N G, Oaknin, A, DiSilvestro, P A, Morgan, M A, Nam, J-H, Leath, C A, Nicum, S, Hagemann, A R, Littell, R D, Cella, D, Baron-Hay, S, Garcia-Donas, J, Mizuno, M, Bell-McGuinn, K, Sullivan, D M, Bach, B A, Bhattacharya, S, Ratajczak, C K, Ansell, P J, Dinh, M H, Aghajanian, C & Bookman, M A 2019, ' Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer ', The New England Journal of Medicine, vol. 381, no. 25, pp. 2403-2415 . https://doi.org/10.1056/NEJMoa1909707
BACKGROUND: Data are limited regarding the use of poly(adenosine diphosphate [ADP]-ribose) polymerase inhibitors, such as veliparib, in combination with chemotherapy followed by maintenance as initial treatment in patients with high-grade serous ovar
Autor:
Elizabeth M. Swisher, Carol Aghajanian, David M. O'Malley, Gini F. Fleming, Scott H. Kaufmann, Douglas A. Levine, Michael J. Birrer, Kathleen N. Moore, Nick M. Spirtos, Mark S. Shahin, Thomas J. Reid, Michael Friedlander, Karina Dahl Steffensen, Aikou Okamoto, Vasudha Sehgal, Peter J. Ansell, Minh H. Dinh, Michael A. Bookman, Robert L. Coleman
Publikováno v:
Swisher, E M, Aghajanian, C, O'Malley, D M, Fleming, G F, Kaufmann, S H, Levine, D A, Birrer, M J, Moore, K N, Spirtos, N M, Shahin, M S, Reid, T J, Friedlander, M, Steffensen, K D, Okamoto, A, Sehgal, V, Ansell, P J, Dinh, M H, Bookman, M A & Coleman, R L 2022, ' Impact of homologous recombination status and responses with veliparib combined with first-line chemotherapy in ovarian cancer in the Phase 3 VELIA/GOG-3005 study ', Gynecologic Oncology, vol. 164, no. 2, pp. 245-253 . https://doi.org/10.1016/j.ygyno.2021.12.003
OBJECTIVE: In the Phase 3 VELIA trial (NCT02470585), PARP inhibitor (PARPi) veliparib was combined with first-line chemotherapy and continued as maintenance for patients with ovarian carcinoma enrolled regardless of chemotherapy response or biomarker
Autor:
Peter Ansell, Karina Dahl Steffensen, Kathleen N. Moore, Aikou Okamoto, Christine K. Ratajczak, Danielle Sullivan, Robert L. Coleman, Minh H. Dinh, Brenden Chen, Scott H. Kaufmann, Bruce A. Bach, Elizabeth M. Swisher, Michael A. Bookman
Publikováno v:
Swisher, E, Kaufmann, S, Okamoto, A, Steffensen, K, Bookman, M, Moore, K, Sullivan, D, Bach, B, Ratajczak, C, Chen, B, Dinh, M, Ansell, P & Coleman, R 2021, ' Characterization of patients with BRCA mutated ovarian cancer who are eligible versus not eligible for PARP inhibitor maintenance therapy: exploratory analysis of the VELIA study ', Gynecologic Oncology, vol. 162, no. Suppl. 1, pp. S106-S107 . https://doi.org/10.1016/S0090-8258(21)00846-5
Objectives: Previous phase 3 trials of front-line maintenance with the PARP inhibitors (PARPi) olaparib and niraparib only included patients (pts) with complete (CR) or partial (PR) response following front-line chemotherapy (CT); both agents were ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88d5f71e65265838f2a5eddbbaef9d45
https://portal.findresearcher.sdu.dk/da/publications/05d497fe-54cd-4876-920b-a4892131e8dd
https://portal.findresearcher.sdu.dk/da/publications/05d497fe-54cd-4876-920b-a4892131e8dd
Autor:
Minh H Dinh, Meegan R Anderson, Michael D McRaven, Gianguido C Cianci, Scott G McCoombe, Z L Kelley, Casey J Gioia, Angela J Fought, Alfred W Rademaker, Ronald S Veazey, Thomas J Hope
Publikováno v:
PLoS Pathogens, Vol 11, Iss 3, p e1004729 (2015)
To gain insight into female-to-male HIV sexual transmission and how male circumcision protects against this mode of transmission, we visualized HIV-1 interactions with foreskin and penile tissues in ex vivo tissue culture and in vivo rhesus macaque m
Externí odkaz:
https://doaj.org/article/8524d76e023a402b84049a15d7a210cb
Autor:
David Cella, N. Khandelwal, K. Benjamin, Danielle Sullivan, Robert L. Coleman, M. A. Bookman, Minh H. Dinh, Rajesh Kamalakar, Angeles Alvarez Secord
Publikováno v:
Oral Plenary.
Objective Veliparib, a poly (ADP-ribose) polymerase inhibitor, was evaluated in a Phase 3 trial (VELIA, NCT02470585) among patients with newly diagnosed stage III/IV high-grade serous epithelial ovarian/fallopian tube/primary peritoneal cancer. VELIA
Autor:
Minh H Dinh, Taha Hirbod, Godfrey Kigozi, Eneniziaogochukwu A Okocha, Gianguido C Cianci, Xiangrong Kong, Jessica L Prodger, Kristina Broliden, Rupert Kaul, David Serwadda, Maria J Wawer, Ronald H Gray, Thomas J Hope
Publikováno v:
PLoS ONE, Vol 7, Iss 7, p e41271 (2012)
It has been hypothesized that increased HIV acquisition in uncircumcised men may relate to a more thinly keratinized inner foreskin. However, published data are contradictory and potentially confounded by medical indications for circumcision. We test
Externí odkaz:
https://doaj.org/article/63ffbd3615a040d79c1651df591891e7
Autor:
Minh H. Dinh, Theresa L. Werner, Danielle Sullivan, Robert L. Coleman, Michael Friedlander, Peter Ansell, Aikou Okamoto, David Cella, Shibani Nicum, Gini F. Fleming, Michael A. Bookman, Joo-Hyun Nam, Carol Aghajanian, Karina Dahl Steffensen, Charles A. Leath, Ana Oaknin, Kathleen N. Moore, Noa Ben-Baruch, Elizabeth M. Swisher, Mark F. Brady
Publikováno v:
Coleman, R L, Fleming, G F, Brady, M F, Swisher, E, Steffensen, K D, Friedlander, M, Okamoto, A, Moore, K, Ben-Baruch, N, Werner, T L, Oaknin, A, Nam, J-H, Leath III, C A, Nicum, S, Cella, D, Sullivan, D M, Ansell, P J, Dinh, M, Aghajanian, C & Bookman, M A 2019, ' VELIA/GOG-3005: Integration of veliparib (V) with front-line chemotherapy and maintenance in women with high-grade serous carcinoma of ovarian, fallopian tube, or primary peritoneal origin (HGSC) ', Annals of Oncology, vol. 30, no. Suppl. 5, LBA3, pp. 895-896 . https://doi.org/10.1093/annonc/mdz394.054
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4ba78554549a175a0c325f3783e0c9a
https://portal.findresearcher.sdu.dk/da/publications/ac0d1969-1c86-4c6d-944a-80a0f8a178b0
https://portal.findresearcher.sdu.dk/da/publications/ac0d1969-1c86-4c6d-944a-80a0f8a178b0
Autor:
Kirsten Timms, Gini F. Fleming, Robert L. Coleman, Michael A. Bookman, Danielle Sullivan, Scott H. Kaufmann, Michael J. Birrer, Bruce A. Bach, Douglas A. Levine, Minh H. Dinh, Vasudha Sehgal, Kathleen N. Moore, Peter Ansell, Carol Aghajanian, Elizabeth M. Swisher, Brenden Chen
Publikováno v:
Gynecologic Oncology. 159:51